These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36781232)

  • 21. Aucubin enhances the antitumor activity of cisplatin through the inhibition of PD-L1 expression in hepatocellular carcinoma.
    Gao ZX; Zhang ZS; Qin J; Zhang MZ; Cao JL; Li YY; Wang MQ; Hou LL; Fang D; Xie SQ
    Phytomedicine; 2023 Apr; 112():154715. PubMed ID: 36821999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humanized disulfide-stabilized diabody against fibroblast growth factor-2 inhibits PD-L1 expression and epithelial-mesenchymal transition in hepatoma cells through STAT3.
    Sun H; Song X; Li C; Li Q; Liu S; Deng N
    IUBMB Life; 2023 Nov; 75(11):957-968. PubMed ID: 37489553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Matrine suppresses stemness of hepatocellular carcinoma cells by regulating β-catenin signaling pathway].
    Dai M; Cai Z; Chen N; Li J; Wen J; Tan L; Guo D
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Oct; 39(10):1239-1245. PubMed ID: 31801708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. siRNA-mediated silencing of Nanog reduces stemness properties and increases the sensitivity of HepG2 cells to cisplatin.
    Alemohammad H; Motafakkerazad R; Asadzadeh Z; Farsad N; Hemmat N; Najafzadeh B; Vasefifar P; Baradaran B
    Gene; 2022 May; 821():146333. PubMed ID: 35182674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pentamethylquercetin Inhibits Hepatocellular Carcinoma Progression and Adipocytes-induced PD-L1 Expression via IFN-γ Signaling.
    Li Z; Gao WQ; Wang P; Wang TQ; Xu WC; Zhu XY; Liu H
    Curr Cancer Drug Targets; 2020; 20(11):868-874. PubMed ID: 32748749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-PD-L1 antibodies promote cellular proliferation by activating the PD-L1-AXL signal relay in liver cancer cells.
    Tanaka T; Koga H; Suzuki H; Iwamoto H; Sakaue T; Masuda A; Nakamura T; Akiba J; Yano H; Torimura T; Kawaguchi T
    Hepatol Int; 2024 Jun; 18(3):984-997. PubMed ID: 37553470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Water extract of sporoderm-broken spores of Ganoderma lucidum enhanced pd-l1 antibody efficiency through downregulation and relieved complications of pd-l1 monoclonal antibody.
    He J; Zhang W; Di T; Meng J; Qi Y; Li G; Zhang Y; Su H; Yan W
    Biomed Pharmacother; 2020 Nov; 131():110541. PubMed ID: 33152901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mRNA expression of programmed cell death ligand 1 and components of the phosphatidylinositol 3-kinase/AKT/phosphatase and tensin homolog pathway in epidermal growth factor receptor mutation-positive lung adenocarcinoma.
    Han K; Zhang Y
    J Cancer Res Ther; 2019; 15(4):914-920. PubMed ID: 31436252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-93-5p expression in tumor tissue and its tumor suppressor function via targeting programmed death ligand-1 in colorectal cancer.
    Chen YL; Wang GX; Lin BA; Huang JS
    Cell Biol Int; 2020 May; 44(5):1224-1236. PubMed ID: 32068322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumol inhibits the expression of programmed cell death-ligand 1 through crosstalk between hypoxia-inducible factor-1α and STAT3 (T705) signaling pathways in hepatic cancer.
    Zuo HX; Jin Y; Wang Z; Li MY; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin CH; Xu GH; Piao LX; Ma J; Jin X
    J Ethnopharmacol; 2020 Jul; 257():112835. PubMed ID: 32278762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IFIT3 accelerates the progression of head and neck squamous cell carcinoma by targeting PD-L1 to activate PI3K/AKT signaling pathway.
    Liu P; Kong X; Yi S; Chen Y; Luo W
    World J Surg Oncol; 2024 Jan; 22(1):34. PubMed ID: 38273364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of PD-L1 by Astragalus polysaccharide attenuates the induction of melanoma stem cell properties and overcomes immune evasion.
    Yu H; Ding G; Gong Q; Ma J; Zhao Y; Wang Y; Qiao X; Cheng X
    BMC Cancer; 2024 Aug; 24(1):1034. PubMed ID: 39169294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tailored modulation of stemness and drug resistance marker characteristics in K-Ras mutant lung cancer cells via PD-L1 gene suppression.
    Unver N; Tavukcuoglu E; Esendagli G
    Life Sci; 2022 Dec; 311(Pt B):121171. PubMed ID: 36396111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of down-regulation of IGF2 gene on the biological characteristics of HCT116 colon cancer stem cells].
    Zhao X; Li J; Liu HQ; Liu XL
    Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):580-586. PubMed ID: 31434448
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanisms regulating PD-L1 expression on tumor and immune cells.
    Chen S; Crabill GA; Pritchard TS; McMiller TL; Wei P; Pardoll DM; Pan F; Topalian SL
    J Immunother Cancer; 2019 Nov; 7(1):305. PubMed ID: 31730010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. L-Type Amino Acid Transporter 1 Regulates Cancer Stemness and the Expression of Programmed Cell Death 1 Ligand 1 in Lung Cancer Cells.
    Liu YH; Li YL; Shen HT; Chien PJ; Sheu GT; Wang BY; Chang WW
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of autophagy on expression of neutrophil programmed death ligand-1 in mice with sepsis].
    Huang J; Sun R; Qi X; Liu L; Yang Y; Sun B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1091-1096. PubMed ID: 31657331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCL9 secreted by tumor-associated dendritic cells up-regulates PD-L1 expression in bladder cancer cells by activating the CXCR3 signaling.
    Xiu W; Luo J
    BMC Immunol; 2021 Jan; 22(1):3. PubMed ID: 33407095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insluin and epithelial growth factor (EGF) promote programmed death ligand 1(PD-L1) production and transport in colon cancer stem cells.
    Chen M; Sharma A; Lin Y; Wu Y; He Q; Gu Y; Xu ZP; Monteiro M; Gu W
    BMC Cancer; 2019 Feb; 19(1):153. PubMed ID: 30770752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Bmi-1-mediated NF-κB signaling pathway on the stem-like properties of CD133+ human liver cancer cells.
    Ma DQ; Zhang YH; Ding DP; Li J; Chen LL; Tian YY; Ao KJ
    Cancer Biomark; 2018; 22(3):575-585. PubMed ID: 29843222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.